Published in Eur Heart J on July 01, 2003
Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement (ARVA) | NCT01293188
Phase Contrast in Valvular Heart Disease | NCT03669666
PRospective Evaluation Complementing Investigation With Acurate Neo Device (PRECISA) | NCT03846557
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol (2011) 1.73
Infective endocarditis in Europe: lessons from the Euro heart survey. Heart (2005) 1.70
Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol (2014) 1.64
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J (2010) 1.63
Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly. Clin Res Cardiol (2008) 1.62
Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J (2010) 1.50
The role of exercise echocardiography in the management of mitral valve disease. Neth Heart J (2013) 1.42
Trends in aortic valve replacement for elderly patients in the United States, 1999-2011. JAMA (2013) 1.41
Review of mitral valve insufficiency: repair or replacement. J Thorac Dis (2014) 1.32
Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol (2011) 1.27
Computed tomography in the evaluation for transcatheter aortic valve implantation (TAVI). Cardiovasc Diagn Ther (2011) 1.13
Dual source multidetector CT-angiography before Transcatheter Aortic Valve Implantation (TAVI) using a high-pitch spiral acquisition mode. Eur Radiol (2011) 1.09
Quality of life among patients with severe aortic stenosis. Neth Heart J (2013) 1.08
Degenerative aortic stenosis. BMJ (2008) 1.07
Transcatheter aortic valve implantation: Current status and future perspectives. World J Cardiol (2011) 1.06
Aortic valve bypass: experience from Denmark. Interact Cardiovasc Thorac Surg (2013) 1.03
Cellular mechanisms of aortic valve calcification. Circ Cardiovasc Interv (2012) 1.03
Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation. Clin Res Cardiol (2011) 1.02
Post-stenotic aortic dilatation. J Cardiothorac Surg (2006) 1.01
Challenges of coronary angiography and intervention in patients previously treated by TAVI. Clin Res Cardiol (2015) 1.01
Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound (2006) 1.01
Clinical course of patients diagnosed with severe aortic stenosis in the Rotterdam area: insights from the AVARIJN study. Neth Heart J (2012) 1.00
Advanced 3-D analysis, client-server systems, and cloud computing-Integration of cardiovascular imaging data into clinical workflows of transcatheter aortic valve replacement. Cardiovasc Diagn Ther (2013) 0.99
Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J (2016) 0.97
Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA (2014) 0.97
A meta-analysis of MitraClip system versus surgery for treatment of severe mitral regurgitation. Ann Cardiothorac Surg (2013) 0.95
First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol (2010) 0.94
Surgery for asymptomatic degenerative aortic and mitral valve disease. Nat Rev Cardiol (2011) 0.94
Surgical Management of Aortic Root Dilatation with Advanced Aortic Regurgitation: Bentall Operation versus Valve-sparing Procedure. Korean J Thorac Cardiovasc Surg (2012) 0.94
Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz (2009) 0.93
[Aortic stenosis]. Clin Res Cardiol (2006) 0.92
Standards for heart valve surgery in a 'Heart Valve Centre of Excellence'. Open Heart (2015) 0.92
Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies. Int J Cardiovasc Imaging (2011) 0.92
Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry. Clin Res Cardiol (2012) 0.92
Low-gradient aortic valve stenosis: value and limitations of dobutamine stress testing. Heart (2006) 0.91
Transcatheter aortic valve replacement in elderly patients. J Geriatr Cardiol (2012) 0.90
Mitral repair best practice: proposed standards. Heart (2005) 0.90
Risk profile and outcomes of aortic valve replacement in octogenarians. World J Cardiol (2011) 0.89
Remodelling of the aortic root in severe tricuspid aortic stenosis: implications for transcatheter aortic valve implantation. Eur Radiol (2009) 0.88
Low-gradient aortic stenosis. Eur Heart J (2016) 0.88
New percutaneous treatments for valve disease. Heart (2007) 0.88
Transcatheter aortic valve replacement: design, clinical application, and future challenges. Yale J Biol Med (2012) 0.88
Surgical treatment of aortic valve disease. Nat Rev Cardiol (2013) 0.87
Beyond adding years to life: health-related quality-of-life and functional outcomes in patients with severe aortic valve stenosis at high surgical risk undergoing transcatheter aortic valve replacement. Curr Cardiol Rev (2013) 0.87
Pulmonary hypertension in mitral regurgitation. J Am Heart Assoc (2014) 0.86
Iterative reconstruction improves evaluation of native aortic and mitral valves by retrospectively ECG-gated thoracoabdominal CTA. Eur Radiol (2012) 0.86
Comprehensive evaluation of preoperative patients with aortic valve stenosis: usefulness of cardiac multidetector computed tomography. Heart (2007) 0.85
Sleep-disordered breathing in patients undergoing transfemoral aortic valve implantation for severe aortic stenosis. Clin Res Cardiol (2013) 0.84
Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation. Blood Coagul Fibrinolysis (2011) 0.84
Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosis. PLoS One (2014) 0.84
Preoperative scallop-by-scallop assessment of mitral prolapse using 2D-transthoracic echocardiography. Cardiovasc Ultrasound (2010) 0.84
Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China. J Thorac Dis (2014) 0.83
Clinical outcome of high-risk patients with severe aortic stenosis and reduced left ventricular ejection fraction undergoing medical treatment or TAVI. PLoS One (2011) 0.83
Genes causing inherited forms of cardiomyopathies. A current compendium. Herz (2009) 0.83
Growing importance of valvular heart disease in the elderly. J Thorac Dis (2016) 0.83
Prospective evaluation of clinical outcomes in all-comer high-risk patients with aortic valve stenosis undergoing medical treatment, transcatheter or surgical aortic valve implantation following heart team assessment. Interact Cardiovasc Thorac Surg (2013) 0.83
Acute improvement in arterial-ventricular coupling after transcatheter aortic valve implantation (CoreValve) in patients with symptomatic aortic stenosis. Int J Cardiovasc Imaging (2011) 0.82
The impact of transcatheter aortic valve implantation on patients' profiles and outcomes of aortic valve surgery programmes: a multi-institutional appraisal. Interact Cardiovasc Thorac Surg (2013) 0.82
The role of TNF-α and TNF superfamily members in the pathogenesis of calcific aortic valvular disease. ScientificWorldJournal (2013) 0.82
Systematic review of aortic valve preservation and repair. Ann Cardiothorac Surg (2013) 0.82
Morphological assessment of the aortic valve using coronary computed tomography angiography, cardiovascular magnetic resonance, and transthoracic echocardiography: comparison with intraoperative findings. Int J Cardiovasc Imaging (2012) 0.82
Transapical mitral implantation of the Tiara bioprosthesis: pre-clinical results. JACC Cardiovasc Interv (2014) 0.81
Impact of valvular heart disease on activities of daily living of nonagenarians: the Leiden 85-plus study a population based study. BMC Geriatr (2010) 0.81
Early and late outcomes after isolated aortic valve replacement in octogenarians: an Australasian Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database Study. Eur J Cardiothorac Surg (2012) 0.81
Early mitral valve repair versus watchful waiting in patients with severe asymptomatic organic mitral regurgitation; rationale and design of the Dutch AMR trial, a multicenter, randomised trial. Neth Heart J (2012) 0.81
Transcatheter aortic valve implantation in the elderly: who to refer? Prog Cardiovasc Dis (2014) 0.81
Balloon expandable transcatheter aortic valve implantation with or without pre-dilation of the aortic valve - rationale and design of a multicenter registry (EASE-IT). BMC Cardiovasc Disord (2014) 0.80
Optimal timing of aortic valve replacement in elderly patients with severe aortic stenosis. Surg Today (2013) 0.80
Treatment and management of mitral regurgitation. Nat Rev Cardiol (2011) 0.80
The pathophysiological basis of pharmacological interventions in CAVD. Neth Heart J (2012) 0.80
Transcatheter aortic valve implantation in very elderly patients: immediate results and medium term follow-up. J Geriatr Cardiol (2015) 0.80
The impact of transcatheter aortic valve implantation on quality of life: results from the German transcatheter aortic valve interventions registry. Clin Res Cardiol (2015) 0.80
Predictors of coronary and carotid atherosclerosis in patients with severe degenerative aortic stenosis. Int J Med Sci (2013) 0.80
Two-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome. Open Heart (2014) 0.80
Drivers of healthcare costs associated with the episode of care for surgical aortic valve replacement versus transcatheter aortic valve implantation. Open Heart (2016) 0.80
Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement. Clin Res Cardiol (2010) 0.79
Safety and efficacy of percutaneous mitral valve repair using the MitraClip® system in patients with diabetes mellitus. PLoS One (2014) 0.79
Stress testing in valve disease. Heart (2007) 0.79
Progress in ring array transducers for real-time 3D ultrasound guidance of cardiac interventional devices. Ultrason Imaging (2011) 0.79
Transcatheter treatment approaches for aortic valve disease. Int J Cardiovasc Imaging (2011) 0.79
Assessment of left ventricle function in patients with symptomatic and asymptomatic aortic stenosis by 2-dimensional speckle-tracking imaging. Med Sci Monit (2012) 0.79
Calcific aortic stenosis. Nat Rev Dis Prim (2016) 0.79
Long-term survival after surgical aortic valve replacement among patients over 65 years of age. Open Heart (2016) 0.79
Contrast volume reduction using third generation dual source computed tomography for the evaluation of patients prior to transcatheter aortic valve implantation. Eur Radiol (2016) 0.79
An analysis of real-world cost-effectiveness of TAVI in South Africa. Cardiovasc J Afr (2014) 0.78
Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease. J Zhejiang Univ Sci B (2015) 0.78
Measurement of the ascending aorta diameter in patients with severe bicuspid and tricuspid aortic valve stenosis using dual-source computed tomography coronary angiography. Int J Cardiovasc Imaging (2011) 0.78
Long term results and predictors of left ventricular function recovery after aortic valve replacement for chronic aortic regurgitation. Ann Thorac Cardiovasc Surg (2015) 0.78
Reproducibility of a novel echocardiographic 3D automated software for the assessment of mitral valve anatomy. Cardiovasc Ultrasound (2016) 0.78
Minimally invasive aortic valve replacement: 12-year single center experience. Ann Cardiothorac Surg (2015) 0.78
Adenosine stress first pass perfusion for the detection of coronary artery disease in patients with aortic stenosis: a feasibility study. Int J Cardiovasc Imaging (2007) 0.78
Validation of a novel clinical prediction score for severe coronary artery diseases before elective coronary angiography. PLoS One (2014) 0.78
The Nordic aortic valve intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: study protocol for a randomised controlled trial. Trials (2013) 0.78
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Universal definition of myocardial infarction. Circulation (2007) 11.69
Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med (2008) 10.03
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet (2007) 7.61
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J (2007) 6.51
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med (2014) 5.98
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg (2012) 5.49
Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med (2009) 5.26
Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol (2007) 5.02
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J (2003) 4.70
Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA (2013) 4.69
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA (2010) 4.56
Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA (2002) 4.48
Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med (2009) 4.19
Soluble CD40 ligand in acute coronary syndromes. N Engl J Med (2003) 4.06
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol (2004) 3.87
Public availability of results of trials assessing cancer drugs in the United States. J Clin Oncol (2013) 3.73
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med (2008) 3.63
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA (2005) 3.54
Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med (2005) 3.52
Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation (2006) 3.50
Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial. JAMA Intern Med (2013) 3.46
Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J (2004) 3.45
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Circulation (2011) 3.38
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37
Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study. PLoS Med (2012) 3.33
A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol (2007) 3.28
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J (2012) 3.19
Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol (2006) 3.16
Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J (2009) 3.14
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 2.91
Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation (2007) 2.85
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J (2005) 2.83
Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol (2008) 2.81
Diagnostic accuracy and clinical utility of noninvasive testing for coronary artery disease. Ann Intern Med (2010) 2.80
Quality of reporting of noninferiority and equivalence randomized trials. JAMA (2006) 2.79
Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol (2008) 2.75
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA (2005) 2.74
Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J (2006) 2.74
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis Rheum (2010) 2.68
Mitral regurgitation. Lancet (2009) 2.64
Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med (2011) 2.62
Unexpected complications of transapical aortic valve implantation. Ann Thorac Surg (2009) 2.61
Gender differences in the management and clinical outcome of stable angina. Circulation (2006) 2.59
Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough. Circulation (2010) 2.56
Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol (2006) 2.54
Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med (2010) 2.52
What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J (2007) 2.52
Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol (2010) 2.51
TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet (2012) 2.50
Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol (2010) 2.50
Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures. Ann Surg (2014) 2.48
Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J (2006) 2.48
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum (2004) 2.44
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment. Arthritis Rheum (2008) 2.41
The infective endocarditis team: recommendations from an international working group. Heart (2013) 2.39
High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol (2005) 2.35
Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation (2010) 2.30
The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J Am Coll Cardiol (2012) 2.27
Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth (2010) 2.26
Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J (2008) 2.23
Prosthesis size and long-term survival after aortic valve replacement. J Thorac Cardiovasc Surg (2003) 2.22
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis (2009) 2.20
2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management. Heart (2013) 2.18
Feasibility of diastolic function assessment with cardiac CT: feasibility study in comparison with tissue Doppler imaging. JACC Cardiovasc Imaging (2011) 2.18
N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol (2013) 2.15
Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J (2008) 2.13
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol (2003) 2.08